Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Specification: Appearance: White crystalline powder
Analysis of the immune-inducible genes of Pplutella xylostella using expressed sequence tags and cDNA microarray
acquired Catalent manufacturing sites Dec 2024 #2 Eli Lilly and Company (NYSE: LLY) Eli Lilly and Company (NYSE: LLY) is the #2-ranked company in the global peptide therapy market and the most important commercial challenger to Novo Nordisk's GLP-1 dominance
Biochimica et Biophysica Acta , 1850(8), 1523-1532
The typical GLP-1 consumer is young, affluent and health-conscious, according to data by British market research company Lumina Intelligence
US$ 28.90
US$ 28.15
US$ 25.95
US$ 21.80
